These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 7522929

  • 1. Immunosuppressants and calcineurin inhibitors, cyclosporin A and FK506, reversibly inhibit epileptogenesis in amygdaloid kindled rat.
    Moia LJ, Matsui H, de Barros GA, Tomizawa K, Miyamoto K, Kuwata Y, Tokuda M, Itano T, Hatase O.
    Brain Res; 1994 Jun 20; 648(2):337-41. PubMed ID: 7522929
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibitory role for calcineurin in stimulus-secretion coupling revealed by FK506 and cyclosporin A in pituitary corticotrope tumor cells.
    Antoni FA, Shipston MJ, Smith SM.
    Biochem Biophys Res Commun; 1993 Jul 15; 194(1):226-33. PubMed ID: 7687429
    [Abstract] [Full Text] [Related]

  • 4. Calcineurin inhibitors, FK506 and cyclosporin A, suppress the NMDA receptor-mediated potentials and LTP, but not depotentiation in the rat hippocampus.
    Lu YF, Tomizawa K, Moriwaki A, Hayashi Y, Tokuda M, Itano T, Hatase O, Matsui H.
    Brain Res; 1996 Aug 05; 729(1):142-6. PubMed ID: 8874888
    [Abstract] [Full Text] [Related]

  • 5. NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs.
    McCaffrey PG, Perrino BA, Soderling TR, Rao A.
    J Biol Chem; 1993 Feb 15; 268(5):3747-52. PubMed ID: 7679116
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin.
    Cardenas ME, Zhu D, Heitman J.
    Curr Opin Nephrol Hypertens; 1995 Nov 15; 4(6):472-7. PubMed ID: 8591053
    [Abstract] [Full Text] [Related]

  • 9. Depletion of the mature CD4+8- thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities.
    Koprak S, Sirotina A, Ok H, Dumont FJ.
    Transplantation; 1996 Mar 27; 61(6):926-32. PubMed ID: 8623162
    [Abstract] [Full Text] [Related]

  • 10. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.
    Fruman DA, Klee CB, Bierer BE, Burakoff SJ.
    Proc Natl Acad Sci U S A; 1992 May 01; 89(9):3686-90. PubMed ID: 1373887
    [Abstract] [Full Text] [Related]

  • 11. The interaction between the catalytic A subunit of calcineurin and its autoinhibitory domain, in the yeast two-hybrid system, is disrupted by cyclosporin A and FK506.
    Chaudhuri B, Hämmerle M, Fürst P.
    FEBS Lett; 1995 Jan 03; 357(2):221-6. PubMed ID: 7528690
    [Abstract] [Full Text] [Related]

  • 12. Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiae.
    Parent SA, Nielsen JB, Morin N, Chrebet G, Ramadan N, Dahl AM, Hsu MJ, Bostian KA, Foor F.
    J Gen Microbiol; 1993 Dec 03; 139(12):2973-84. PubMed ID: 7510323
    [Abstract] [Full Text] [Related]

  • 13. Only in the presence of immunophilins can cyclosporin and FK506 disrupt in vivo binding of calcineurin A to its autoinhibitory domain yet strengthen interaction between calcineurin A and B subunits.
    Chaudhuri B, Stephan C.
    Biochem Biophys Res Commun; 1995 Oct 13; 215(2):781-90. PubMed ID: 7488022
    [Abstract] [Full Text] [Related]

  • 14. FK506, a Ca2+/calmodulin-dependent phosphatase inhibitor, inhibits the induction of long-term potentiation in the rat hippocampus.
    Lu YF, Hayashi Y, Moriwaki A, Tomizawa K, Matsui H.
    Neurosci Lett; 1996 Feb 23; 205(2):103-6. PubMed ID: 8907327
    [Abstract] [Full Text] [Related]

  • 15. Factors responsible for the Ca(2+)-dependent inactivation of calcineurin in brain.
    Stemmer PM, Wang X, Krinks MH, Klee CB.
    FEBS Lett; 1995 Oct 30; 374(2):237-40. PubMed ID: 7589543
    [Abstract] [Full Text] [Related]

  • 16. Presynaptic modulation of cortical synaptic activity by calcineurin.
    Victor RG, Thomas GD, Marban E, O'Rourke B.
    Proc Natl Acad Sci U S A; 1995 Jul 03; 92(14):6269-73. PubMed ID: 7541535
    [Abstract] [Full Text] [Related]

  • 17. FK506 in bone marrow transplantation.
    Hemenway C.
    Blood; 1995 Nov 01; 86(9):3611-2. PubMed ID: 7579473
    [No Abstract] [Full Text] [Related]

  • 18. Only 'de novo' long-term depression (LTD) in the rat hippocampus in vitro is blocked by the same low concentration of FK506 that blocks LTD in the visual cortex.
    Hodgkiss JP, Kelly JS.
    Brain Res; 1995 Dec 24; 705(1-2):241-46. PubMed ID: 8821755
    [Abstract] [Full Text] [Related]

  • 19. Growth inhibitory effects of FK506 and cyclosporin A independent of inhibition of calcineurin.
    Richter A, Davies DE, Alexander P.
    Biochem Pharmacol; 1995 Jan 31; 49(3):367-73. PubMed ID: 7531976
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE.
    Chem Immunol; 1994 Jan 31; 59():128-55. PubMed ID: 7524531
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.